Ilan Ganot - 10 Feb 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
CEO & President, Director
Signature
/s/ Erin P. Brennan as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
10 Feb 2022
Net transactions value
-$519
Form type
4
Filing time
08 Mar 2022, 15:39:22 UTC
Previous filing
31 Jan 2022
Next filing
04 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale $519 -463 -16% $1.12 2,518 10 Feb 2022 Wife F1
holding SLDB Common Stock 1,202,093 10 Feb 2022 Direct F2
holding SLDB Common Stock 290,914 10 Feb 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2 Represents 1,141,462 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Includes 2,272 shares acquired by Mr. Ganot under the Solid Biosciences Employee Stock Purchase Plan on September 1, 2021.
F3 Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.